⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockIsraelNasdaqCM

PYPD

PolyPid Ltd.

Healthcare · Biotechnology

5.20USD

-0.1300 (-2.44%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
1)

Comparable Revenue

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY————15.0M8.7M
Q1——————
Q2——————
Q3————15.0M—
Q4————0.0—
2)

Comparable Earnings Per Share

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY-2.31-1.42-1.64-2.09-.890-1.23
Q1————-.350—
Q2———-.780-.350—
Q3———-.370.270—
Q4——

Fiscal period: Reported, Estimated. Reported figures: Yahoo Finance (limited history). Estimates are sell-side consensus for periods that have not reported. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.

—
-.410
-.405
—